# HRGen GIA LIMS — L99N100XN30 Fix/Test/Verify Report

**Date:** 2026-10-15  
**Input artifact:** `HRGen-GIA-LIMS-FULL-PRODUCT-L99N30-LEVEL4A.zip`  
**Scope:** Fix high-priority clinical workflow and tenant RLS defects, run available verification, package a portable source artifact.

## Changes applied

1. **Pre-analytical gates:** result entry and report release reject orders without `specimenStatus === ACCEPTED`.
2. **Specimen controls:** acceptance rejects post-validation mutation and duplicate acceptance; requested tube code is checked against accession label requirements; acceptance records receipt time; rejection requires a valid reason and archives prior specimen state in `specimenHistory`.
3. **Analyzer import:** active instrument must belong to the authenticated tenant; imported test codes must exactly match accession test codes without omissions, extras or duplicates; accession test metadata is preserved; incoming values are left `UNREVIEWED`.
4. **Unsafe fast-track:** disabled because the former path fabricated QC, calibration and pathologist sign-off evidence.
5. **Batch validation:** disabled fail-closed until it can call the canonical single-order validation service. This avoids a partial validator bypass.
6. **Analyzer simulator:** disabled in production, requires a tenant-owned active instrument, and leaves values unreviewed.
7. **PostgreSQL RLS:** `loadState()` now sets `app.tenant_id` per tenant and selects only tenant-owned rows. Tenant-scoped writes and platform-record reads/writes set the transaction-local tenant context.
8. **Test discovery:** Playwright only discovers `*.spec.js`, excluding Vitest unit tests.
9. Added `validation/CLINICAL_GATE_FIX_VERIFY.js`, wired into `npm run qa:all`, and generated `package-lock.json` for clean target-platform dependency installation.

## Verification results

| Check | Result | Evidence / limitation |
|---|---|---|
| `npm run qa:all` | PASS | Existing behavior/result-report checks, final verifier, 86 break-it checks, Westgard 23/23, edge cases 10/10, QC tenant 7/7, clinical gate verifier 17/17 |
| `npm run forensic` | PASS | Static source verifier 36/36 |
| `npm run build77` | PASS | 77/77 declared feature surfaces; this is not production qualification |
| `npm run verify:final` | PASS | Static syntax and feature checks |
| `npm test` | BLOCKED | Vitest could not load because the bundled `node_modules` contained Windows Rollup binaries but not `@rollup/rollup-linux-x64-gnu` |
| `npm run test:e2e` | BLOCKED | Playwright test discovery is fixed; Chromium executable is not installed in this environment |
| Live PostgreSQL RLS test | NOT RUN | No PostgreSQL client/server available in this environment |
| Live server / analyzer / provider / OQ-PQ-UAT / DR | NOT RUN | Requires target environment and configured secrets/providers/hardware |

## Release decision

**Not production-qualified.** Static verification passes, and the identified unsafe bypasses are now fail-closed. Live database tenant isolation, unit tests on a clean target-platform install, browser E2E, analyzer integration, OQ/PQ/UAT and disaster-recovery validation remain release gates. Do not use for clinical production until those gates are executed and signed off.

## Run on the target OS

1. Extract the source bundle.
2. Copy `.env.example` to `.env`; configure PostgreSQL and strong secrets.
3. Run `npm ci`.
4. Start PostgreSQL with the supplied Docker Compose file, then start the app.
5. Run `npm run qa:all`, `npm test`, and `npx playwright install chromium` followed by `npm run test:e2e` against a configured live server.
6. Execute tenant-isolation integration tests against a non-superuser application database role before enabling production traffic.

## Follow-on UI/API build — 2026-10-15

### Implemented

1. Replaced the Analyzer Edge placeholder with server-backed instrument, reagent-lot, calibration, IQC and accession data.
2. Added authenticated tenant-filtered `GET /api/instruments`, `GET /api/reagents/lots`, and `GET /api/calibrations` endpoints.
3. Added controlled analyzer result import UI using the existing exact-test-set import API. The UI explicitly labels it as controlled import, not a live device connection, and tells operators that imported values remain UNREVIEWED.
4. Added QC approval workflow UI for ACCEPTED specimens with RESULTS_ENTERED state. It presents only PASS IQC runs with a matching accession test code and requires matching instrument, in-date reagent lot and PASS calibration selections.
5. Tightened `/api/qc/approve/:orderId` so the selected instrument must match the QC run, the QC test code must be present in the accession, and the active reagent lot must belong to that instrument.
6. Tightened reagent lot registration: valid expiry, required lot number, active same-tenant instrument and duplicate-lot protection per instrument.
7. Replaced Pathologist placeholder with a live order authorization cockpit showing QC provenance, critical flags, state-specific actions, re-authenticated sign-off and report view.
8. Added real stock-on-hand rows to Inventory, sourced from `/api/inventory/items`.
9. Removed fast-track release and batch-validation actions from the active worklist/result-entry UI. Those unsafe server paths remain fail-closed.

### Follow-on verification

- `npm run qa:all`: PASS, including `L99N100XN30_UI_ANALYZER_VERIFY` (20/20).
- `npm run forensic`: PASS (36 static checks).
- `npm run build77`: PASS (77/77 declared feature surfaces; not production qualification).
- `npm run verify:final`: PASS.
- `node --check server.js`, `node --check server/platformRoutes.js`, and inline frontend JavaScript syntax check: PASS.
- `npx playwright test --list`: discovers 1 browser E2E test. `npm run test:e2e` was attempted and failed before test logic because the Chromium executable is not installed in this environment.
- Live PostgreSQL, authenticated HTTP workflows, physical analyzer connectivity, and clinical OQ/PQ/UAT remain NOT RUN.

### Remaining release blockers

- `npm test` still requires a clean platform-native dependency install; the bundled local `node_modules` are not a valid portable test runtime.
- Install Chromium and execute Playwright against a configured application.
- Run live PostgreSQL RLS and two-tenant isolation tests with a non-superuser application role.
- Validate analyzer-specific ASTM/HL7 mappings against actual device output and verify full per-test QC provenance for multi-analyte accessions before clinical production.
- Complete backup/restore, DR, load/chaos, OQ/PQ/UAT and signed release approval.

**Release decision remains BLOCKED for clinical production.**
